Search research articles
Contact Us
Filters
Showing results (691-700 of 731) with videos related to
Page
of 74
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 16, 2020
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis
Sofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
ESMO Open
|
August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)
M Hamann, M Christgen, O Gluz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 17, 2020
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study
Nina B K Jensen, Richard Pötter, Sofia Spampinato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2026
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
R Dent, Z Shao, P Schmid, et al.
Gynecologic Oncology
|
August 17, 2020
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study
J Knoth, R Pötter, I M Jürgenliemk-Schulz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 3, 2021
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
Kathrin Kirchheiner, Stéphanie Smet, Ina M Jürgenliemk-Schulz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 19, 2023
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023
David Cibula, Maria Rosaria Raspollini, François Planchamp, et al.
Allergy
|
April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement
Jean Bousquet, H J Schünemann, P J Bousquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2026
Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N=7914)
O Gluz, U Nitz, M Christgen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 31, 2023
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
Sofia Spampinato, Kari Tanderup, Jacob C Lindegaard, et al.
Page
of 74
Search research articles
Search
Showing results (691-700 of 731) with videos related to
Sort By:
Page
of 74
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 16, 2020
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis
Sofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
ESMO Open
|
August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)
M Hamann, M Christgen, O Gluz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 17, 2020
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study
Nina B K Jensen, Richard Pötter, Sofia Spampinato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2026
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
R Dent, Z Shao, P Schmid, et al.
Gynecologic Oncology
|
August 17, 2020
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study
J Knoth, R Pötter, I M Jürgenliemk-Schulz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 3, 2021
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
Kathrin Kirchheiner, Stéphanie Smet, Ina M Jürgenliemk-Schulz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 19, 2023
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023
David Cibula, Maria Rosaria Raspollini, François Planchamp, et al.
Allergy
|
April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement
Jean Bousquet, H J Schünemann, P J Bousquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2026
Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N=7914)
O Gluz, U Nitz, M Christgen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 31, 2023
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
Sofia Spampinato, Kari Tanderup, Jacob C Lindegaard, et al.
Page
of 74